Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
574 Leser
Artikel bewerten:
(2)

China's Public Health System Primed for Digital Innovation Online/Offline Service Delivery 'Huge Growth Opportunity', says Ping An Co-CEO

Finanznachrichten News

HONG KONG and SHANGHAI, June 25, 2021 /PRNewswire/ -- Ping An is investing further in its healthcare ecosystem to meet the growing public healthcare needs in China, says Jessica Tan, Co-CEO of Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318).

Ms. Tan addressed the Fortune Global Forum, a virtual event for the leaders of the Fortune Global 500, the world's largest companies.

"This is a huge growth opportunity for the next five to 10 years," Ms. Tan said. "We see the opportunity accelerating, and it's time for a second phase of online consultation." Online medical consultations in China grew from 3% to 5% before the COVID-19 pandemic to 20% at its peak last year, Ms. Tan said. That could grow to 34% as consumers are becoming used to online consultations and more cities are now accepting social health insurance online as regulations changed during the pandemic.

"What will fuel the next stage of growth is how you can integrate the online and offline health aspects," she added.

Ping An has built a healthcare ecosystem that helps to address the challenges raised by China's rapidly aging population, rising public healthcare costs and a shortage of medical professionals. As of December 31, 2020, the ecosystem served 21,000 health management authorities in 158 cities, processed more than one billion online consultations, and partnered with more than 3,700 hospitals and 151,000 pharmacies.

Digital technology makes it possible for people even outside China's Tier 1 and Tier 2 cities to get access to quality healthcare, Ms. Tan said. Ping An Good Doctor, China's leading online healthcare platform, has an in-house medical team of about 2,200 as well as a network of 22,000 top specialists across the country. The smart healthcare team of Ping An Smart City is providing technology tools that now support about 750,000 doctors across the country, such as AskBob, an artificial-intelligence clinical decision support system, and medical imaging and analysis. For doctors in lower-tier cities who have less experience and training than those in the country's leading hospitals, these tools can help to significantly improve the accuracy of diagnoses and treatment recommendations.

The healthcare ecosystem creates synergies with Ping An's main businesses. In 2020, nearly 61% of Ping An's more than 218 million financial customers used services from the healthcare ecosystem. In the past four years, about 15% to 20% of Ping An's new financial customers each year were sourced from the healthcare ecosystem. Ping An's insurance customers and their families are assigned dedicated family doctor online. They also have access to services such as annual health check-ups, chronic disease management, such as monitoring diabetes, access to 22,000 specialists and treatment for critical illnesses.

Ping An's comprehensive healthcare ecosystem encompasses twelve entities, which work hand-in-hand to serve the healthcare industry on all fronts, including healthcare management authorities, patients, service providers, and payers. These include: the smart healthcare team of Ping An Smart City, which serves the government and offline health care service providers; Ping An Good Doctor, which focuses on patients and online health care service providers; and Ping An HealthKonnect, which serves payers. Ping An ranked first globally by the number of digital healthcare patent applications at the end of 2020. In addition to establishing its own businesses and partnering with others, Ping An has invested in nearly 100 companies in the healthcare industry through Ping An Overseas Holdings and other platforms.

Ms. Tan was number six on Fortune's list of the World's 50 Greatest Leaders in 2021, and number two on Fortune's Most Powerful Women International list in 2020.

About Ping An Group
Ping An Insurance (Group) Company of China, Ltd. ("Ping An") is a world-leading technology-powered retail financial services group. With over 220 million retail customers and 611 million internet users, Ping An is one of the largest financial services companies in the world. Ping An focuses on two over-arching domains of activity, "pan financial assets" and "pan health care", covering the provision of financial and health care services through our integrated financial services platform and our ecosystems; in financial services, health care, auto services and smart city services. Our "finance + technology" and "finance + ecosystem" transformation strategies aim to provide customers and internet users with innovative and simple products and services using technology. As China's first joint stock insurance company, Ping An is committed to upholding the highest standards of corporate reporting and corporate governance. The Group is listed on the stock exchanges in Hong Kong and Shanghai. Ping An ranked 6th in the Forbes Global 2000 list in 2021 and ranked 21st in the Fortune Global 500 list in 2020. Ping An also ranked 49th in the 2021 WPP Kantar Millward Brown BrandZTM Top 100 Most Valuable Global Brands list.

For more information, please visit www.group.pingan.com and follow us on LinkedIn - PING AN.

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.